Why Diphenhydramine (Benadryl) Is a Poor Long-Term Sleep Strategy

Physician Article Dr. Brian Harris
Why Diphenhydramine (Benadryl) Is a Poor Long-Term Sleep Strategy
Why this matters

Diphenhydramine is popular for sleep largely because it is easy to buy and easy to misunderstand. Common does not mean smart, and over-the-counter does not mean low-risk. In fact, it is a classic example of a medication that looks more helpful on night one than it does after a few weeks of use.

In plain language

Most people know diphenhydramine as Benadryl or the "PM" in various pain meds. It’s an old-school antihistamine that makes you drowsy, but it’s a poor choice for long-term sleep for three reasons: 1. Fast Tolerance: Your body gets used to it very quickly (often in just a few days), so it stops working unless you take more. 2. Next-Day Fog: It has a long half-life, meaning it’s often still in your system the next morning, leaving you feeling "hungover" or groggy. 3. The "Drying" Effect: It blocks a chemical called acetylcholine, which can cause dry mouth, constipation, and in older adults, serious confusion or memory issues.

"OTC" means it's available without a prescription, but it doesn't mean it's the best tool for chronic insomnia.

Clinical deep dive

First-generation antihistamines like diphenhydramine are generally discouraged for the chronic treatment of insomnia due to their unfavorable side effect profile and rapid development of tachyphylaxis.

Pharmacodynamics and Side Effects

  • Anticholinergic Burden: Diphenhydramine is a potent antagonist at muscarinic receptors. This leads to common "anti-SLUD" side effects (Dry mouth, urinary retention, constipation).
  • CNS Impact: Because it easily crosses the blood-brain barrier, it interferes with cognitive function. In elderly populations, it significantly increases the risk of delirium, falls, and urinary retention (appearing prominently on the Beers Criteria).
  • Tolerance: Histaminergic systems up-regulate quickly in response to H1-antagonism, often rendering the drug ineffective for sedation within 3–4 nights of consecutive use.

Clinical Recommendation

Patients using OTC diphenhydramine should be screened for underlying primary sleep disorders or psychophysiologic insomnia. For those requiring a histamine-based approach for sleep maintenance, ultra-low-dose doxepin (3–6mg) is a much cleaner alternative, as it is highly selective for the H1 receptor and lacks the significant anticholinergic burden of diphenhydramine.